Search results

Page results

• World-first genotyping test that could transform care for people with sickle cell

  The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.

• Focus on cancer vaccine trials at UCLH

  Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.

• Complementary and Alternative Medicine Library and Information Service (CAMLIS)

  CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.

• ‘Before midnight' blood cells helped save life of UCLH patient

  Read more about a UCLH patient saved by special 'before midnight' transfusions.

• Their Majesties The King and Queen hear families' cancer stories at UCLH

  King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today. 

• First participant in Europe joins new myeloma trial at UCLH

  UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.

• RESPOND services for healthcare professionals

  RESPOND – Information for healthcare professionals and services working with asylum seekers

• 1,000 RSV vaccines administered at UCLH

  UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.

• NHS Staff Survey 2024 – we’re the top acute trust to work at for third year running!

  Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!

• First participant joins new Parkinson’s Disease study at UCLH

  UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.